A Clinical Observation of Xiaoji Decoction for Intermediate and Late Stages of Lung Cancer
- VernacularTitle:消积饮治疗中晚期肺癌的临床观察
- Author:
Junren LU
;
Weisheng LIU
;
Kai XU
;
Wanyin WU
;
Yulong LIU
;
Diying ZHU
- Publication Type:Journal Article
- Keywords:
LUNG NEOPLASMS/TCD therapy;
LUNG NEOPLASMS/drug therapy;
XIAOJI DECOCTION/ ther. use;
STRENGTHENING SPLEEN;
CLEARING HEAT ANTITOXICANT
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2001;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
ive] To observe the therapeutic effects of Xiaoji Decoction (XD) in treating intermed iate and late stages of lung cancer. [ Methods] One hundred and twelve patients with lung cancer in stage ? -? were randomly allocated to Group A, Group B and Group C. Group A ( n = 49) was treated with XD alone, Group B ( n = 33 ) was treated with various chemotherapeutic regimens according to the histo-logical types of lung cancer: CAP regimen for lung squamous carcinoma, EP regimen for lung adenocarci-noma and CE regimen for small cell carcinoma of lung, In Group C, 30 patients were treated with chemo therapy combined with XD. Symptomatic relief, life quality, tumor size, distant metastasis, sub-types of T lymphocytes, survival period and side effects in the three groups were evaluated after one course of treatment. [Results] The effects of XD on tumor size were evaluated by the effective rate and stabilized rate. They were 4.08%and 53.06%, 21.21% and 48.48%, and 46.67%and 76.67%in Group A, Group B and Group C respectively. The differences between Group A and Group B were significant ( P
